Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

UK leads venture capital investment in Europe in Q1 2025, according to an update from KPMG. The report reveals latest VC ...

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ to discuss investing in biotech and the oversaturation in the sector. He said that looking at ...

Directives from President Donald Trump's administration to freeze grant funding from the National Institutes of Health may ...

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -8.30%), Recursion Pharmaceuticals ( RXRX -3.98%), and CRISPR Therapeutics ( CRSP -1.49%), plunged in March, with the stocks down 35.3%, ...

On the buying side, ARK’s ARKG ETF acquired 2161 shares of biopharmaceutical giant Amgen Inc (NASDAQ: AMGN ), with a total investment of around $599,223. This purchase signals a growing interest in ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

SOLASTA Bio has appointed three senior business and industry experts to support the company’s UK and US growth.